研究者業績
基本情報
- 所属
- 藤田医科大学 岡崎医療センター 医学部 医学科 呼吸器低侵襲外科学 講座教授
- 学位
- 博士(医学)
- J-GLOBAL ID
- 200901055419428598
- researchmap会員ID
- 5000024891
研究分野
1論文
114-
General thoracic and cardiovascular surgery 2025年7月18日
-
General thoracic and cardiovascular surgery 2025年4月21日OBJECTIVES: Uniportal video-assisted thoracoscopic surgery (U-VATS) is gaining global recognition as a minimally invasive approach. However, its current status and issues in Japan remain unclear. This study aimed to assess U-VATS adoption and barriers among Japanese thoracic surgeons through a nationwide survey. METHODS: The Japanese Uniportal VATS Interest Group conducted an online survey of 3287 thoracic surgeons on the Japan Association for Chest Surgery mail list. Responses were collected from October 25 to November 30, 2024, yielding 851 valid responses (25.9%) from 497 institutions (78.0% of JACS-registered institutions). RESULTS: The adoption rate of U-VATS among the institutions was 42.5%. However, the proportions of thoracic surgeons who primarily performed lobectomy, segmentectomy, and wedge resection using U-VATS were 10.3%, 10.2%, and 22.0%, respectively. The main reasons for non-adoption included concerns regarding safety and surgical precision (57.2%), preference for other approaches (50.9%), and lack of instruments (48.8%). Among surgeons with no prior U-VATS experience, 34.1% were willing to adopt it. To facilitate broader adoption, respondents highlighted the need for troubleshooting resources (61.3%), high-precision surgical videos (59.0%), and hands-on training programs (51.5%). CONCLUSION: Despite the relatively high institutional adoption rate, the proportion of thoracic surgeons using U-VATS as the primary approach remained low. Key barriers include concerns about safety and surgical precision, limited educational opportunities, and a lack of scientific evidence on U-VATS in Japan. To promote the wider adoption of U-VATS, it is essential to develop structured educational programs and generate evidence to ensure both safety and surgical precision.
-
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 67(4) 2025年3月28日We report subxiphoid uniportal robotic thymectomy without intercostal access using the da Vinci Xi multi-port robot system. A 4-cm vertical incision was made 1 cm caudal to the xiphoid process. The AIRSEAL ROBOTIC SOLUTION, an air seal system compatible with the da Vinci port was used to insufflate CO2 at 8 mmHg. During port insertion, the left and right hands were crossed into the wound, with the camera, left hand, and right hand inserted in the order from the anterior chest to the dorsal side. To reduce the interference between the ports at the head, a key technique is to pull the camera port forward to prevent it from colliding with the other ports. Subxiphoid uniportal robotic thymectomy using the da Vinci Xi is a technique that combines excellent surgical visibility from the subxiphoid process, minimal invasiveness and enhanced operability provided by the robotic system.
-
General thoracic and cardiovascular surgery 72(12) 810-813 2024年12月We performed the first case of major lung resection using the hinotori™ surgical robot system, which is a new surgical support robot system developed in Japan. A left lower lobectomy and subcarinal lymph node dissection were performed. The operation time was 3 h and 5 min, the cockpit time (console time) was 2 h and 5 min, and the blood loss was 40 g. Although the hinotori™ surgical robot system requires further improvements to be used for lung cancer surgery, even in its current state, there is no difference in operability compared to the da Vinci robot, and it is possible to perform the same surgery. Further evaluation with additional cases is required in future.
-
Journal of thoracic disease 16(10) 6778-6788 2024年10月31日BACKGROUND: We previously reported on subxiphoid uniportal thymectomy (SUT) and subxiphoid robotic thymectomy (SRT). This descriptive study aimed to evaluate the feasibility and safety of both SUT and SRT techniques. METHODS: Between March 2011 and December 2022, 268 patients underwent subxiphoid thymectomy. In cases demonstrating no evidence of invasion into other organs, SUT was selected due to its minimal invasiveness. In cases where the tumor was in contact with the innominate vein or those with suspected invasion into other organs, SRT with additional intercostal ports was selected due to the enhanced operability provided by the robotic system. The patients' backgrounds and the perioperative outcomes of each technique were evaluated. RESULTS: SUT was performed in 207 patients, while SRT was performed in 61 patients. In the SUT group, 15 patients required an additional intercostal port, and 2 patients required a median sternotomy; the SUT completion rate was 91.78%. The median operative time was 117.00 [interquartile range (IQR), 88.00-148.50] min, with a median blood loss of 5.00 (IQR, 1.00-5.00) mL. Combined resection was performed in 11 (5.31%) patients, and postoperative complications were observed in 4 patients (1.93%). None of the patients in the SRT group required median sternotomy. The median operative time was 203.00 (IQR, 158.00-278.00) min, with a median blood loss of 5.00 (IQR, 5.00-22.00) mL. Combined resection was performed in 14 patients (22.95%), and postoperative complications were observed in 5 patients (8.20%). No mortalities occurred in either group. CONCLUSIONS: Subxiphoid thymectomy is a safe and feasible technique for both early and advanced stages of the disease requiring complex surgical procedures.
MISC
110-
日本外科学会雑誌 115(2) 162-162 2014年3月5日
-
ANNALS OF THORACIC SURGERY 97(2) 718-719 2014年2月 査読有り
-
ANNALS OF THORACIC SURGERY 94(6) 2176-2177 2012年12月 査読有り
-
日本呼吸器外科学会雑誌 26(4) 373-379 2012年 査読有り胸腔鏡下手術患者群において持続傍脊椎神経ブロックの有用性を後ろ向きに検討した.完全鏡視下肺切除術を行った連続した92名のうち32名で術中に傍脊椎神経ブロックを施し,術直後から0.2%塩酸ロピバカイン水和物注射液(アナペイン注2mg/ml),全量200 mlを3ml/時で持続投与した.同鎮痛法を行わない患者群と術後疼痛パラメーターを比較した.術当日から翌日の疼痛程度は傍脊椎神経ブロック施行群で有意に低値であった(Visual Analogue Scaleスコア平均値28±16 vs.43±18,p<0.01).疼痛増強時の臨時鎮痛薬投与量は同鎮痛法施行群でより少なかった.同鎮痛法に関連した副作用はみられなかった.胸腔鏡下肺切除術患者において持続傍脊椎神経ブロックは安全で簡便,かつ有効な疼痛緩和法であった.
-
ANNALS OF THORACIC SURGERY 93(1) 334-336 2012年1月 査読有り
-
日本呼吸器外科学会誌 24(4) 727-732 2010年 査読有り手術支援ロボットダヴィンチSサージカルシステムは,より複雑で細やかな手術操作を可能とし,3次元による正確な画像情報を取得できるため,より安全かつ侵襲の少ない手術を可能とするかもしれない.我々は肺癌症例に対し,このダヴィンチSサージカルシステムを使用し,肺葉切除+縦隔リンパ節郭清を行った.症例は56歳女性.右上葉肺腺癌cT1bN0N0 stage IAに対し,右上葉切除+縦隔リンパ節郭清を施行した.剥離操作はすべてダヴィンチシステム下に行い,術野展開,吸引操作とステープリングは助手が行った.手術時間は6時間48分,出血量は234gであった.多関節を有する器具は自由度が高く,胸腔内における剥離操作をより自然なものにする.これは,通常のVATSにおける直線的な器具での操作と比較して大きな利点であった.ダヴィンチシステムによるロボット支援は,今後のさらなるシステムの改良と相まって,これまで技術的に困難と考えられていた手術を可能とするかもしれない.
-
肺癌 48(5) 581-581 2008年10月5日
-
肺癌 46(5) 535-535 2006年11月5日
-
日本外科学会雑誌 104 230-230 2003年4月30日
-
The Japanese Journal of THORACIC AND CARDIOVASCULAR SURGERY 51(Suppl.) 149-149 2003年3月
-
藤田学園医学会誌 26(2) 109-113 2002年12月38歳女.23歳で第1子出産後より眼瞼下垂が出現し重症筋無力症と診断され内服治療を受けていた.30歳頃より増悪し,38歳時に拡大胸腺摘出術を施行した.胸部CT上は明らかな胸腺腫は認められなかった.切除胸腺の病理組織所見は脂肪化した退縮胸腺であった.術後経過は良好で症状も改善した.病理組織学的には,切除胸腺は脂肪組織が80%以上を占め髄質部にmild lymphoid follicular hyperplasiaを伴う退縮胸腺であった.免疫組織染色によるthymidylate synthase発現は陽性,dihydropyrimidine dehydrogenase発現は陽性,thymidine phosphorylase発現は陰性であった
書籍等出版物
1講演・口頭発表等
82共同研究・競争的資金等の研究課題
2-
日本学術振興会 科学研究費助成事業 2017年4月 - 2020年3月
-
日本学術振興会 科学研究費助成事業 2004年 - 2006年